Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-5,737
Closed -$413K – 418
2024
Q3
$413K Sell
5,737
-10,613
-65% -$749K 0.05% 322
2024
Q2
$1.13M Buy
16,350
+5,783
+55% +$422K 0.14% 197
2024
Q1
$846K Buy
10,567
+8,235
+353% +$734K 0.07% 251
2023
Q4
$255K Sell
2,332
-4,961
-68% -$513K 0.02% 396
2023
Q3
$735K Buy
+7,293
New +$838K 0.06% 282
2022
Q4
– Sell
-5,105
Closed -$409K – 497
2022
Q3
$409K Buy
+5,105
New +$482K 0.08% 278
2021
Q3
– Sell
-1,370
Closed -$188K – 458
2021
Q2
$188K Sell
1,370
-115
-8% -$15.7K 0.04% 458
2021
Q1
$194K Buy
+1,485
New +$179K 0.06% 295
2020
Q4
– Sell
-301
Closed -$24K – 946
2020
Q3
$24K Buy
+301
New +$24.5K 0.02% 554
2020
Q2
– Sell
-7,221
Closed -$414K – 962
2020
Q1
$414K Buy
7,221
+6,182
+595% +$570K 0.09% 284
2019
Q4
$116K Buy
+1,039
New +$111K 0.01% 729

Other funds holding CNMD

FORA Capital's CNMD Position: Q4 2024 in Review

FORA Capital sold out of CONMED (CNMD) in Q4 2024, closing a stake of 5,737 shares — an estimated $413K sold.

FORA Capital first reported a position in CNMD in Q4 2019 and held it in 11 quarters. The position peaked at $1.13M in Q2 2024. 280 funds tracked by Wall St. Rank hold CNMD as of Q4 2024.

  • FORA Capital reported no remaining CONMED position as of Q4 2024 after selling out during the quarter.
  • FORA Capital sold 5,737 CONMED shares in Q4 2024, an estimated $413K.
  • FORA Capital first reported a position in CONMED in Q4 2019 and held it in 11 quarters.
  • FORA Capital's CONMED position peaked at $1.13M in Q2 2024.
  • 280 funds tracked by Wall St. Rank held CONMED as of Q4 2024.

Based on FORA Capital's 13F filing for Q4 2024, filed 14 Feb 2025.